Literature DB >> 15900516

The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptors.

Takafumi Horishita1, Kouichiro Minami, Yasuhito Uezono, Munehiro Shiraishi, Junichi Ogata, Takashi Okamoto, Tadanori Terada, Takeyoshi Sata.   

Abstract

The neurosteroids pregnenolone, progesterone, and dehydroepiandrosterone (DHEA) occur naturally in the nervous system. They act on neural tissues, participate in neuronal signaling, and are reported to alter neuronal excitability via nongenomic mechanisms. Muscarinic receptors have important roles in neuronal functions in the brain and autonomic nervous system. In this study, we investigated the effects of pregnenolone, progesterone, and DHEA on M(1) and M(3) muscarinic receptors using the Xenopus oocyte expression system. Pregnenolone and progesterone inhibited the acetylcholine (ACh)-mediated responses of M(1) and M(3) receptors expressed in Xenopus oocytes, whereas DHEA did not. The half-maximal inhibitory concentrations (IC(50)) for pregnenolone inhibition of M(1) receptor- and M(3) receptor-mediated currents were 11.4 and 6.0 microM respectively; the IC(50) values for progesterone inhibition of M(1) receptor- and M(3) receptor-mediated currents were 2.5 and 3.0 microM respectively. The selective protein kinase C (PKC) inhibitor GF109203X had little effect on the pregnenolone or progesterone inhibition of the ACh-induced currents in Xenopus oocytes expressing M(1) or M(3) receptors. The inhibitory effects of pregnenolone and progesterone were overcome at higher concentrations of ACh. Pregnenolone and progesterone inhibited the [(3)H]quinuclidinyl benzilate (QNB) binding to M(1) and M(3) receptor expressed in Xenopus oocytes, and Scatchard plot analysis of [(3)H]QNB binding revealed that pregnenolone and progesterone altered the K(d) value and the B(max), indicating noncompetitive inhibition. In conclusion, pregnenolone and progesterone inhibited M(1) and M(3) receptor functions noncompetitively by the mechanism independent of PKC and by interfering with ACh binding to the receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900516     DOI: 10.1007/s00210-005-1022-1

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  45 in total

Review 1.  Development of neurosteroid-based novel psychotropic drugs.

Authors:  D S Reddy; S K Kulkarni
Journal:  Prog Med Chem       Date:  2000

2.  The effects of isoflurane on native and chimeric muscarinic acetylcholine receptors: the role of protein kinase C.

Authors:  S H Do; G L Kamatchi; M E Durieux
Journal:  Anesth Analg       Date:  2001-08       Impact factor: 5.108

Review 3.  Molecular biology of muscarinic acetylcholine receptors.

Authors:  J Wess
Journal:  Crit Rev Neurobiol       Date:  1996

Review 4.  Neurosteroids and GABAA receptor function.

Authors:  J J Lambert; D Belelli; C Hill-Venning; J A Peters
Journal:  Trends Pharmacol Sci       Date:  1995-09       Impact factor: 14.819

5.  Physiological aspects of steroids with anaesthetic properties.

Authors:  M Holzbauer
Journal:  Med Biol       Date:  1976-08

6.  Inhibition by tramadol of muscarinic receptor-induced responses in cultured adrenal medullary cells and in Xenopus laevis oocytes expressing cloned M1 receptors.

Authors:  M Shiraishi; K Minami; Y Uezono; N Yanagihara; A Shigematsu
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

Review 7.  Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence.

Authors:  H C Fibiger
Journal:  Trends Neurosci       Date:  1991-06       Impact factor: 13.837

8.  The neurosteroid pregnenolone sulfate increases cortical acetylcholine release: a microdialysis study in freely moving rats.

Authors:  M Darnaudéry; M Koehl; M Pallarés; M Le Moal; W Mayo
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

9.  A neurosteroid anesthetic, alphaxalone, inhibits nicotinic acetylcholine receptors in cultured bovine adrenal chromaffin cells.

Authors:  Munehiro Shiraishi; Izumi Shibuya; Kouichiro Minami; Yasuhito Uezono; Takashi Okamoto; Nobuyuki Yanagihara; Susumu Ueno; Yoichi Ueta; Akio Shigematsu
Journal:  Anesth Analg       Date:  2002-10       Impact factor: 5.108

10.  Neurosteroids affect spatial/reference, working, and long-term memory of female rats.

Authors:  C A Frye; J D Sturgis
Journal:  Neurobiol Learn Mem       Date:  1995-07       Impact factor: 2.877

View more
  3 in total

1.  Regulation of neurosteroid biosynthesis by neurotransmitters and neuropeptides.

Authors:  Jean Luc Do Rego; Jae Young Seong; Delphine Burel; Jerôme Leprince; David Vaudry; Van Luu-The; Marie-Christine Tonon; Kazuyoshi Tsutsui; Georges Pelletier; Hubert Vaudry
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-24       Impact factor: 5.555

2.  Oxidative Stress-Mediated Brain Dehydroepiandrosterone (DHEA) Formation in Alzheimer's Disease Diagnosis.

Authors:  Georges Rammouz; Laurent Lecanu; Vassilios Papadopoulos
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-08       Impact factor: 5.555

3.  Dexmedetomidine inhibits muscarinic type 3 receptors expressed in Xenopus oocytes and muscarine-induced intracellular Ca2+ elevation in cultured rat dorsal root ganglia cells.

Authors:  Atsushi Takizuka; Kouichiro Minami; Yasuhito Uezono; Takafumi Horishita; Toru Yokoyama; Munehiro Shiraishi; Takeshi Sakurai; Akio Shigematsu; Yoichi Ueta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-12       Impact factor: 3.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.